Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. | Front Pharmacol | 2022 | 35784761 | PubTator, text mining | PubMed |
| Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling. | Front Cardiovasc Med | 2022 | 35783871 | PubTator, text mining | PubMed |
| Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. | Genes Dis | 2022 | 35782973 | PubTator, text mining | PubMed |
| RecQ Helicase Somatic Alterations in Cancer. | Front Mol Biosci | 2022 | 35782872 | PubTator, text mining | PubMed |
| Rad53 arrests leading and lagging strand DNA synthesis via distinct mechanisms in response to DNA replication stress. | Bioessays | 2022 | 35778827 | PubTator, text mining | PubMed |
| A combinatorial system to examine the enzymatic repair of multiply damaged DNA substrates. | Nucleic Acids Res | 2022 | 35776119 | PubTator, text mining | PubMed |
| Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35769911 | PubTator, text mining | PubMed |
| Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets. | Front Genet | 2022 | 35754835 | PubTator, text mining | PubMed |
WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer. | Bioessays | 2022 | 35751457 | PubTator, text mining | PubMed |
| Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome. | Cancers (Basel) | 2022 | 35740649 | PubTator, text mining | PubMed |
| Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing. | Nat Commun | 2022 | 35739111 | PubTator, text mining | PubMed |
| Genomic analysis of Rad26 and Rad1-Rad10 reveals differences in their dependence on Mediator and RNA polymerase II. | Genome Res | 2022 | 35738899 | PubTator, text mining | PubMed |
| Tunable Synthesis of Hydrogel Microfibers via Interfacial Tetrazine Ligation. | Biomacromolecules | 2022 | 35737940 | PubTator, text mining | PubMed |
| The Integration of Gold Nanoparticles with Polymerase Chain Reaction for Constructing Colorimetric Sensing Platforms for Detection of Health-Related DNA and Proteins. | Biosensors (Basel) | 2022 | 35735568 | PubTator, text mining | PubMed |
| Affinity of disordered protein complexes is modulated by entropy-energy reinforcement. | Proc Natl Acad Sci U S A | 2022 | 35727975 | PubTator, text mining | PubMed |
| Water Availability, Soil Characteristics, and Confounding Effects on the Patterns of Biocrust Diversity in the Desert Regions of Northern China. | Front Plant Sci | 2022 | 35720603 | PubTator, text mining | PubMed |
| A highly sensitive homogeneous electrochemiluminescence biosensor for flap endonuclease 1 based on branched hybridization chain reaction amplification and ultrafiltration separation. | Bioelectrochemistry | 2022 | 35716581 | PubTator, text mining | PubMed |
| CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. | Cell Mol Biol Lett | 2022 | 35715750 | PubTator, text mining | PubMed |
| Exploring the genetic space of the DNA damage response for cancer therapy through CRISPR-based screens. | Mol Oncol | 2022 | 35708734 | PubTator, text mining | PubMed |
| MP-Net: Deep learning-based segmentation for fluorescence microscopy images of microplastics isolated from clams. | PLoS One | 2022 | 35704628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=41